We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
After years of struggling with the Disability Tax Credit (DTC), Wendell Dempsey breathed a sigh of relief last week when all members of the House of Commons Standing Committee on Finance (FINA) unanimously supported an amendment to the Federal Budget that would ensure all Canadians living with type 1 diabetes (T1D) can access this credit. […]
A focus of JDRF’s Improving Lives research is to improve glucose control and reduce the burden of self-management by advancing the development of new drugs and devices for people with type 1 diabetes (T1D). The study: Can adding an approved glucose-lowering drug to treatment with a closed-loop insulin delivery system improve glucose control in T1D? […]
On April 20, 2022, the Canadian Institutes of Health Research (CIHR) and JDRF announced new funding for type 1 diabetes (T1D) research in the areas of precision medicine and psychosocial health. This new tranche of funding stems from the 2021 Federal Budget announcement on strategic investments in diabetes research. The JDRF-CIHR Partnership to Defeat Diabetes […]
National Volunteer Week takes place from April 24-30, 2022, as organizations across the country celebrate those who generously donate their time and talents to their community. The National Volunteer Week theme for 2022 is Volunteering Is Empathy in Action, affirming the strong connection between volunteerism and empathy. The theme also emphasizes that Volunteers Bring Heart […]
Making history is not easy. After discovering insulin 100 years ago, Frederick Banting and Charles Best spent tireless nights isolating and purifying it to treat type 1 diabetes (T1D). Their discovery saved millions of lives. Generous donors have fueled further research breakthroughs, yet those living with T1D still require insulin to stay alive. Canada gave […]
A significant part of JDRF’s research strategy is funding innovative therapies that can lead to treatment for type 1 diabetes (T1D) and eventually a cure. As part of this it was announced on April 6, 2022, that Vancouver, BC, Canada and New York, NY based company Aspect Biosystems (“Aspect”), are partnering to develop a bioengineered […]
Beginning April 4th, 2022, to honour 100 years since Leonard Thompson received the first successful insulin, injection five volunteers will brave the elements and live atop a 40-foot flagpole for 100 hours to unite Canadians and raise funds for JDRF’s $100 Million Campaign to Accelerate in support of type 1 diabetes (T1D) research. Why a […]
Approximately 300,000 Canadians live with type 1 diabetes (T1D), an autoimmune disease that destroys the cells in the pancreas responsible for making insulin. The discovery of the insulin hormone over 100 years ago meant the first treatment for the disease, whereas previously a diagnosis meant certain death. But a century later, it remains the only […]
Approximately 300,000 Canadians live with type 1 diabetes (T1D), an autoimmune disease that destroys the cells in the pancreas responsible for making insulin. The discovery of the insulin hormone over 100 years ago meant the first treatment for the disease, which previously a diagnosis meant certain death. But a century later, it remains the only […]
Tuesday, March 8, 2022 marks International Women’s Day (IWD) around the word. For this year, the theme is #BreakTheBias. The theme challenges us to imagine a gender equal world, that is free from bias, stereotypes, and discrimination. To envision a world that is diverse, equitable, and inclusive and where difference is valued and celebrated. JDRF […]
Last summer, Brain Canada and JDRF officially launched the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a unique program that supports research on interventions that address mental health concerns in people with type 1 diabetes (T1D). Living with a chronic illness like diabetes is hard. As a result […]
Christine MacGibbon: University Student, Former Dancer & Model Diagnosed: 9 years old Christine’s journey as a T1D warrior began 24 years ago. This was a pivotal moment for her and her family, as it had an immense emotional and physical toll. In her personal and professional life, Christine has naturally evolved into an advocate, learning […]
Notifications
